Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries. From the FU-Registry

Journal of Cardiology

Volumn 61, Issue 2, 2013, Pages 117-121

  Sugihara, Makoto ^a   Miura, Shin ichiro ^a   Nishikawa, Hiroaki ^a   Ike, Amane ^a   Mori, Ken ^a   Iwata, Atsushi ^a   Kawamura, Akira ^a   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bare metal stent; Drug eluting stent; Small coronary artery

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY LESION; ARTERY OCCLUSION; ARTICLE; BARE METAL STENT; CARDIOVASCULAR RISK; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE REGISTRY; DRUG ELUTING STENT; DYSLIPIDEMIA; FEMALE; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; STABLE ANGINA PECTORIS;

AGED; COMPARATIVE EFFECTIVENESS RESEARCH; CORONARY RESTENOSIS; CORONARY THROMBOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; REGISTRIES; RISK FACTORS; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 84873081451     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.09.008     Document Type: Article

References (17)

1. Hamasaki S., Tei C. Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention. J Cardiol 2011, 57:231-238.
2. Takayama T., Hiro T., Hirayama A. Stent thrombosis and drug-eluting stents. J Cardiol 2011, 58:92-98.
3. Nakazawa G. Stent thrombosis of drug eluting stent: pathological perspective. J Cardiol 2011, 58:84-91.
4. Grines C.L., Bonow R.O., Casey D.E., Gardner T.J., Lockhart P.B., Moliterno D.J., O'Gara P., Whitlow P., American Heart Association, American College of Cardiology, Society of Cardiovascular Angiography and Interventions, American College of Surgeons, American Dental Associations, American College of Physicians Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. Circulation 2007, 115:813-818.
5. Hsieh I.C., Chien C.C., Chang H.J., Chern M.S., Hung K.C., Lin F.C., Wu D. Acute and long-term outcomes of stenting in coronary vessels >3.0mm, 3.0-2.5mm, and <2.5mm. Catheter Cardiovasc Interv 2001, 53:314-322.
6. Mauri L., Orav E.J., Kuntz R.E. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 2005, 111:3435-3442.
7. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W., et al. Clinical end points in coronary stent trials: a case of standardized definitions. Circulation 2007, 115:2344-2351.
8. Ortolani P., Ardissino D., Cavallini C., Bramucci E., Indolfi C., Aquilina M., Marzocchi A. Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (a SES-SMART substudy). Am J Cardiol 2005, 96:1393-1398.
9. Park K.W., Hwang S.J., Kwon D.A., Oh B.H., Park Y.B., Chae I.H., Gwon H.C., Park S.J., Seung K.B., Ahn T., Yoon J.H., Jang Y.S., Jeong M.H., Tahk S.J., Kim H.S., et al. Characteristics and predictors of drug-eluting stent thrombosis-results from the multicenter 'Korea Stent Thrombosis (KoST)' Registry. Circ J 2011, 75:1626-1632.
10. Urban P., Gershlick A.H., Guagliumi G., Guyon P., Lotan C., Schofer J., Seth A., Sousa J.E., Wijns W., Berge C., Deme M., Stoll H.P., e-Cypher Investigators Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 2006, 113:1434-1441.
11. Lemos P.A., Arampatzis C.A., Saia F., Hoye A., Degertekin M., Tanabe K., Lee C.H., Cummins P., Smits P.C., McFadden E., Sianos G., de Feyter P., van der Giessen W.J., van Domburg R.T., Serruys P.W. Treatment of very small vessels with 2.5mm diameter sirolimus-eluting stent. Am J Cardiol 2004, 93:633-636.
12. Ishigami K., Uemura S., Morikawa Y., Soeda T., Okayama S., Nishida T., Takemoto Y., Onoue K., Somekawa S., Takeda Y., Kawata H., Horii M., Saito Y. Long-term follow-up of neointimal coverage of sirolimus-eluting stents evaluation with optical coherence tomography. Circ J 2009, 73:2300-2307.
13. Menozzi A., Solinas E., Ortolani P., Repetto A., Saia F., Piovaccari G., Manari A., Magagnini E., Vignali L., Bonizzoni E., Merlini P.A., Cavallini C., Ardissino D., SES-SMART Investigators Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study. Eur Heart J 2009, 30:2095-2101.
14. Togni M., Eber S., Widmer J., Billinger M., Wenaweser P., Cook S., Vogel R., Seiler C., Eberli F.R., Maier W., Corti R., Roffi M., Lüscher T.F., Garachemani A., Hess O.M., et al. Impact of vessel size on outcome after implantation of sirolimus-eluting stent and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. J Am Coll Cardiol 2007, 50:1123-1131.
15. Mehilli J., Dibra A., Kastrati A., Pache J., Dirschinger J., Schömig A., Intracoronary Drug-Eluting Stenting to Abrogate Restenosis in Small Arteries (ISAR-SMART 3) Study Investigators Randomised trial of paclitaxel and sirolimus eluting stents in small coronary vessels. Eur Heart J 2006, 27:260-266.
16. Togni M., Eber S., Widmer J., Billinger M., Wenaweser P., Cook S., Vogel R., Seiler C., Eberli F.R., Maier W., Corti R., Roffi M., Lüscher T.F., Garachemani A., Hess O.M., et al. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a sub-group analysis of the SIRTAX trial. J Am Coll Cardiol 2007, 50:1123-1131.
17. Tahara S., Chamié D., Baibars M., Alraies C., Costa M. Optical coherence tomography endpoints in stent clinical investigations: strut coverage. Int J Cardiovasc Imaging 2011, 27:271-287.